alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › tau-targeting

tau-targeting

4 studies tagged tau-targeting, dated 2021-09-17 to 2024-09-30. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Tau‑targeting multifunctional nanocomposite based on tannic acid-metal for near-infrared fluorescence/magnetic resonance bimodal imaging-guided combinational therapy in Alzheimer's disease 2024-09-30
  2. Considerations for biomarker strategies in clinical trials investigating tau-targeting therapeutics for Alzheimer's disease 2024-05-21
  3. A Review on Tau Targeting Biomimetics Nano Formulations: Novel Approach for Targeting Alzheimer's Diseases 2024-01-01

Studies

4 studies carry this tag.

Date range

2021 to 2024

Top journals

  • Alzheimer's & dementia : the journal of the Alzheimer's Association 1
  • Central nervous system agents in medicinal chemistry 1
  • Theranostics 1
  • Translational neurodegeneration 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Tau‑targeting multifunctional nanocomposite based on tannic acid-metal for near-infrared fluorescence/magnetic resonance bimodal imaging-guided combinational therapy in Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 45 out of 100. Theranostics 2024-09-30 Drug development

    The nanocomposite facilitates Mn-enhanced magnetic resonance (MR) imaging and near-infrared (NIR) fluorescence imaging.

  2. Considerations for biomarker strategies in clinical trials investigating tau-targeting therapeutics for Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 45 out of 100. Translational neurodegeneration 2024-05-21 Drug development

    The use of biomarker-led clinical trial designs has been transformative for investigating amyloid-targeting therapies for Alzheimer's disease (AD).

  3. A Review on Tau Targeting Biomimetics Nano Formulations: Novel Approach for Targeting Alzheimer's Diseases

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Central nervous system agents in medicinal chemistry 2024-01-01 Drug development

    Central nervous system disorders are prevalent, profoundly debilitating, and poorly managed.

  4. A critical appraisal of tau-targeting therapies for primary and secondary tauopathies

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2021-09-17 Drug development

    The reasons for these clinical failures are unclear but could be linked to the clearing of physiological forms of tau by non-specific drugs.

All topic tags with their study counts